[HTML][HTML] Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme
Background Coordinated efforts to collect large-scale data sets provide a basis for systems
level understanding of complex diseases. In order to translate these fragmented and …
level understanding of complex diseases. In order to translate these fragmented and …
Tissue‐specific pioneer factors associate with androgen receptor cistromes and transcription programs
P Pihlajamaa, B Sahu, L Lyly, V Aittomäki… - The EMBO …, 2014 - embopress.org
Androgen receptor ( AR ) binds male sex steroids and mediates physiological androgen
actions in target tissues. Ch IP ‐seq analyses of AR ‐binding events in murine prostate, kidney …
actions in target tissues. Ch IP ‐seq analyses of AR ‐binding events in murine prostate, kidney …
[HTML][HTML] Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
Aims/hypothesis This prospective, observational study examines associations between 51
urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 …
urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 …
[HTML][HTML] Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: a randomised trial using nuclear magnetic resonance …
…, TJ Vahlberg, HT Koskela, V Aittomäki… - European Journal of …, 2022 - journals.lww.com
BACKGROUND Pharmacometabolomics uses large-scale data capturing methods to uncover
drug-induced shifts in the metabolic profile. The specific effects of anaesthetics on the …
drug-induced shifts in the metabolic profile. The specific effects of anaesthetics on the …
Identification of prognostic groups in high-grade serous ovarian cancer treated with platinum–taxane chemotherapy
P Chen, K Huhtinen, K Kaipio, P Mikkonen, V Aittomäki… - Cancer research, 2015 - AACR
Disseminated high-grade serous ovarian cancer (HGS-OvCa) is an aggressive disease
treated with platinum and taxane combination therapy. While initial response can be favorable, …
treated with platinum and taxane combination therapy. While initial response can be favorable, …
Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes
Aims This study examines associations between 51 urinary metabolites and risk of progression
of diabetic nephropathy in individuals with type 1 diabetes by employing an automated …
of diabetic nephropathy in individuals with type 1 diabetes by employing an automated …
Systematic use of computational methods allows stratification of treatment responders in glioblastoma multiforme
Background: Cancers are complex diseases whose comprehensive characterization
requires genome-scale molecular data at multiple levels from genetics to transcriptomics and …
requires genome-scale molecular data at multiple levels from genetics to transcriptomics and …
MicroRNA regulation in breast cancer-a Bayesian analysis of expression data
V Aittomäki - 2016 - aaltodoc.aalto.fi
MicroRNAs are a class of small, non-coding RNAs, which regulate gene expression post-transcriptionally.
They downregulate genes by targeting messenger RNA transcripts and …
They downregulate genes by targeting messenger RNA transcripts and …
fasting samples are not required for NMR metabolic profiling studies of cardiovascular disease risk: prospective data for 4,400 individuals profiled few weeks apart
E Tikkanen, N Kanerva, V Aittomaki, S Männistö… - Circulation, 2019 - Am Heart Assoc
Background: Metabolic profiling technologies have uncovered a wealth of blood biomarkers
predictive of cardiovascular disease (CVD) incidence and progression. Due to dietary …
predictive of cardiovascular disease (CVD) incidence and progression. Due to dietary …
Abstract A31: High-grade serous ovarian cancer subtyping identifies pathways for targeted therapy.
…, P Chen, K Kaipio, P Mikkonen, V Aittomäki… - Clinical Cancer …, 2016 - AACR
Introduction: We recently identified three prognostic groups for high-grade serous ovarian
cancers (HGS-OvCa) patients treated with platinum and taxane using transcriptomics and …
cancers (HGS-OvCa) patients treated with platinum and taxane using transcriptomics and …